
Sign up to save your podcasts
Or


In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Antonio González-Martín to discuss the results of overall survival in the PRIMA trial. Dr. Antonio González-Martín specializes in the treatment of gynaecological and breast cancer and is the chairman of GEICO (Spanish group for investigation in ovarian and gynaecological cancer). He is also the representative of GEICO in ENGOT (European Network for Gynaecological Oncological Trials), and was the President of this Group for the period 2018-2020. In addition, he is one of the representatives of GEICO in Gynaecologic Cancer InterGroup (GCIG), and has served as chair of the ovarian cancer committee for the period 2014-2020. He is also a member of the board of the Spanish Society of Medical Oncology (SEOM), and a member of GEICAM and SOLTI breast cancer cooperative groups.
By ijgcgroup5
33 ratings
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Antonio González-Martín to discuss the results of overall survival in the PRIMA trial. Dr. Antonio González-Martín specializes in the treatment of gynaecological and breast cancer and is the chairman of GEICO (Spanish group for investigation in ovarian and gynaecological cancer). He is also the representative of GEICO in ENGOT (European Network for Gynaecological Oncological Trials), and was the President of this Group for the period 2018-2020. In addition, he is one of the representatives of GEICO in Gynaecologic Cancer InterGroup (GCIG), and has served as chair of the ovarian cancer committee for the period 2014-2020. He is also a member of the board of the Spanish Society of Medical Oncology (SEOM), and a member of GEICAM and SOLTI breast cancer cooperative groups.

120 Listeners

112,451 Listeners

56,739 Listeners

206 Listeners

8,594 Listeners

18 Listeners

57 Listeners

34 Listeners

312 Listeners

28 Listeners

192 Listeners